#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage III Nasopharyngeal cancer Hyperchylomicronaemia Oropharyngeal cancer recurrent Narcolepsy Lip and/or oral cavity cancer Idiopathic pulmonary fibrosis KBG syndrome Microscopic polyangiitis Thalassaemia PIK3CA-activated mutation Mantle cell lymphoma Lymphatic malformation Systemic sclerosis pulmonary Emphysema More trials…

    Learn about Rare Diseases

    Lymphangioma – Trials in Disease Loeys-Dietz syndrome – Treatment Rosai-Dorfman syndrome – Diagnostics IgA nephropathy Gaucher’s disease type I – Basic Information Netherton’s syndrome – Basic Information Activated PI3 kinase delta syndrome – Basic Information Thrombotic thrombocytopenic purpura – Treatment Fabry’s disease – Life with Disease Propionic acidaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lasn01 Artemisia Vulgaris (312) Microcrystalline Cellulose Ibuprofen Lysine Sodium Glycerophosphate Sertindole HAFNIUM OXIDE Remestemcel ALLO-QUADCAR01-T Nirogacestat Hydrobromide Glpg3667 Fumarate Clopidogrel Tretinoin Metolazone Ambrosia Artemisiifolia (302) Rasagiline Daridorexant SIGVOTATUG VEDOTIN Rineterkib ARLOCABTAGENE AUTOLEUCEL More therapies…

    Learn about Your Condition

    Neuralgia Contusion Eyelid ptosis Neurofibrosarcoma Joint stabilisation Lichen planus Netherton's syndrome Thrombocytosis Hypoalbuminaemia Erdheim-Chester disease Post cardiac arrest syndrome Hereditary ataxia Hypotonia Foot deformity Cystic fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier De Laval

Centre Hospitalier De Laval

33 Rue Du Haut Rocher, Laval, 53000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    • Salbutamol
    Austria Bulgaria Czechia Denmark Finland France +10

  • Study on Stopping Beta-Blockers in Heart Failure Patients with Recovered Heart Function Using Carvedilol and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Dapagliflozin Propanediol
    • Hydrochlorothiazide
    • Losartan Potassium
    France

  • Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    • Azd5004
    Bulgaria Czechia Denmark Finland France Germany +8

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!